Light-Adjustable Lens: Clinical Results and Case Reports

Rivera, Robert

Light-Adjustable Lens: Clinical Results and Case Reports

Tuesday, April 29, 2014: 2:01 PM

Room 151B (Boston Convention and Exhibition Center)

Robert P. Rivera, MD, Hoopes Vision, Draper, UT, USA

Robert K. Maloney, MD, Maloney Vision Institute, Los Angeles, CA, USA

Doyle Stulting, MD, PhD, Woolfson Eye Institute, Atlanta, GA, USA

T. Hunter Newsom, MD, Newsom Eye, Tampa, Florida, USA

Vance M. Thompson, MD, Vance Thompson Vision, Sioux Falls, SD, USA

Kevin L. Waltz, OD, MD, Eye Surgeons of Indiana, Indianapolis, IN, USA

Light Adjustable Lens FDA Study Group, Calhoun Vision, Inc., Pasadena, CA, USA

Narrative Responses:

Purpose
To present case reports on visual and refractive outcomes achieved after the implantation of a UV-Light Adjustable Lens.

Methods
Eyes with corneal cylinder 0.75D-2.00D undergoing cataract surgery are implanted with the Light Adjustable Lens (LAL: Calhoun Vision, Pasadena, CA). Adjustment of lens power to correct residual spherical error and astigmatism is done 17-21 days postop, followed by an optional second adjustment, and then two lock-in treatments to freeze the lens power. The refractive goal was emmetropia in all eyes.

Results
Three case reports of the use of the LAL will be reported.

Conclusion
In these cases, patient post-refractive error was significantly reduced by the application of a UV-light adjustment resulting in excellent visual outcomes.